{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:22:28Z","timestamp":1794856948110,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81971518"],"award-info":[{"award-number":["81971518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"key-area research and development program of guangdong province","award":["2019B020236001"],"award-info":[{"award-number":["2019B020236001"]}]},{"name":"shenzhen key laboratory of ankylosing spondylitis","award":["ZDSYS20190902092851024"],"award-info":[{"award-number":["ZDSYS20190902092851024"]}]},{"DOI":"10.13039\/501100003453","name":"natural science foundation of guangdong province","doi-asserted-by":"publisher","award":["2018A030313232"],"award-info":[{"award-number":["2018A030313232"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"health welfare fund project of futian district","award":["FTWS2020078"],"award-info":[{"award-number":["FTWS2020078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The zinc transporters Zrt- and Irt-related protein (ZIP\/SLC39) are overexpressed in human tumors and correlate with poor prognosis; however, their contributions to carcinogenesis and chemoresistance in osteosarcoma (OS) remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We collected 64 OS patient tissues with (<jats:italic>n<\/jats:italic>\u00a0=\u200912) or without (<jats:italic>n<\/jats:italic>\u00a0=\u200952) chemotherapy. The expression levels of ZIP10 were measured by immunohistochemistry and applied to prognostic analysis. ZIP10 was knocked down or overexpressed in OS cell lines to explore its effect on proliferation and chemoresistance. RNA sequencing, quantitative real-time PCR, and western blotting analysis were performed to explore ZIP10-regulated downstream target genes. A xenograft mouse model was established to evaluate the mechanisms by which ZIP10 modulates chemoresistance in OS cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The expression of ZIP10 was significantly induced by chemotherapy and highly associated with the clinical outcomes of OS. Knockdown of ZIP10 suppressed OS cell proliferation and chemoresistance. In addition, ZIP10 promoted Zn content-induced cAMP-response element binding protein (CREB) phosphorylation and activation, which are required for integrin \u03b110 (ITGA10) transcription and ITGA10-mediated PI3K\/AKT pathway activation. Importantly, ITGA10 stimulated PI3K\/AKT signaling but not the classical FAK or SRC pathway. Moreover, overexpression of ZIP10 promoted ITGA10 expression and conferred chemoresistance. Treatment with the CREB inhibitor 666\u201315 or the PI3K\/AKT inhibitor GSK690693 impaired tumor chemoresistance in ZIP10-overexpressing cells. Finally, a xenograft mouse model established by subcutaneous injection of 143B cells confirmed that ZIP10 mediates chemotherapy resistance in OS cells via the ZIP10-ITGA10-PI3K\/AKT axis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We demonstrate that ZIP10 drives OS proliferation and chemoresistance through ITGA10-mediated activation of the PI3K\/AKT pathway, which might serve as a target for OS treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13046-021-02146-8","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T08:02:57Z","timestamp":1635321777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K\/AKT pathway"],"prefix":"10.1186","volume":"40","author":[{"given":"Hongyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaopeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujia","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"issue":"4","key":"2146_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/fon-2016-0261","volume":"13","author":"L Kager","year":"2017","unstructured":"Kager L, Tamamyan G, Bielack S. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol. 2017;13(4):357\u201368.","journal-title":"Future Oncol"},{"issue":"2","key":"2146_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1200\/JCO.2017.75.1743","volume":"36","author":"JS Whelan","year":"2018","unstructured":"Whelan JS, Davis LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 2018;36(2):188\u201393.","journal-title":"J Clin Oncol"},{"issue":"27","key":"2146_CR3","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","volume":"33","author":"MS Isakoff","year":"2015","unstructured":"Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33(27):3029\u201335.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2146_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/CCO.0000000000000456","volume":"30","author":"SJ Strauss","year":"2018","unstructured":"Strauss SJ, Whelan JS. Current questions in bone sarcomas. Curr Opin Oncol. 2018;30(4):252\u20139.","journal-title":"Curr Opin Oncol"},{"key":"2146_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-nutr-033009-083312","volume":"29","author":"LA Lichten","year":"2009","unstructured":"Lichten LA, Cousins RJ. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr. 2009;29:153\u201376.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"2146_CR6","doi-asserted-by":"publisher","first-page":"612","DOI":"10.20892\/j.issn.2095-3941.2020.0106","volume":"17","author":"J Wang","year":"2020","unstructured":"Wang J, Zhao H, Xu Z, Cheng X. Zinc dysregulation in cancers and its potential as a therapeutic target. Cancer Biol Med. 2020;17(3):612\u201325.","journal-title":"Cancer Biol Med"},{"issue":"5","key":"2146_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1158\/1078-0432.CCR-09-2405","volume":"16","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Bharadwaj U, Logsdon CD, Chen C, Yao Q, Li M. ZIP4 regulates pancreatic cancer cell growth by activating IL-6\/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res. 2010;16(5):1423\u201330.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2146_CR8","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1111\/cas.13737","volume":"109","author":"H Jin","year":"2018","unstructured":"Jin H, Liu P, Wu Y, Meng X, Wu M, Han J, et al. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer. Cancer Sci. 2018;109(9):2946\u201356.","journal-title":"Cancer Sci"},{"issue":"3","key":"2146_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1053\/j.gastro.2019.10.038","volume":"158","author":"M Liu","year":"2020","unstructured":"Liu M, Zhang Y, Yang J, Cui X, Zhou Z, Zhan H, et al. ZIP4 increases expression of transcription factor ZEB1 to promote integrin alpha3beta1 signaling and inhibit expression of the gemcitabine transporter ENT1 in pancreatic cancer cells. Gastroenterology. 2020;158(3):679\u201392.","journal-title":"Gastroenterology"},{"issue":"2","key":"2146_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12011-019-01807-2","volume":"194","author":"K Alluri","year":"2020","unstructured":"Alluri K, Nair K, Kotturu SK, Ghosh S. Transcriptional regulation of zinc transporters in human osteogenic sarcoma (Saos-2) cells to zinc supplementation and zinc depletion. Biol Trace Elem Res. 2020;194(2):360\u20137.","journal-title":"Biol Trace Elem Res"},{"issue":"32","key":"2146_CR11","doi-asserted-by":"publisher","first-page":"20383","DOI":"10.1074\/jbc.273.32.20383","volume":"273","author":"L Camper","year":"1998","unstructured":"Camper L, Hellman U, Lundgren-Akerlund E. Isolation, cloning, and sequence analysis of the integrin subunit alpha10, a beta1-associated collagen binding integrin expressed on chondrocytes. J Biol Chem. 1998;273(32):20383\u20139.","journal-title":"J Biol Chem"},{"key":"2146_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-94-017-9153-3_4","volume":"819","author":"E Lundgren-Akerlund","year":"2014","unstructured":"Lundgren-Akerlund E, Aszodi A. Integrin alpha10beta1: a collagen receptor critical in skeletal development. Adv Exp Med Biol. 2014;819:61\u201371.","journal-title":"Adv Exp Med Biol"},{"issue":"Pt 5","key":"2146_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1242\/jcs.01678","volume":"118","author":"T Bengtsson","year":"2005","unstructured":"Bengtsson T, Aszodi A, Nicolae C, Hunziker EB, Lundgren-Akerlund E, Fassler R. Loss of alpha10beta1 integrin expression leads to moderate dysfunction of growth plate chondrocytes. J Cell Sci. 2005;118(Pt 5):929\u201336.","journal-title":"J Cell Sci"},{"issue":"10","key":"2146_CR14","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1158\/2159-8290.CD-15-1481","volume":"6","author":"T Okada","year":"2016","unstructured":"Okada T, Lee AY, Qin LX, Agaram N, Mimae T, Shen Y, et al. Integrin-alpha10 dependency identifies RAC and RICTOR as therapeutic targets in high-grade myxofibrosarcoma. Cancer Discov. 2016;6(10):1148\u201365.","journal-title":"Cancer Discov"},{"issue":"4","key":"2146_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/cancers11040587","volume":"11","author":"TM Munksgaard","year":"2019","unstructured":"Munksgaard TM, Chmielarska MK, Krona C, Huang X, Kundu S, Schmidt L, et al. Integrin alpha10, a novel therapeutic target in glioblastoma, regulates cell migration, proliferation, and survival. Cancers (Basel). 2019;11(4):587.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2146_CR16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/stem.3332","volume":"39","author":"M Ma","year":"2021","unstructured":"Ma M, Yang W, Cai Z, Wang P, Li H, Mi R, et al. SMAD-specific E3 ubiquitin ligase 2 promotes angiogenesis by facilitating PTX3 degradation in MSCs from patients with ankylosing spondylitis. Stem Cells. 2021;39(5):581\u201399.","journal-title":"Stem Cells"},{"key":"2146_CR17","doi-asserted-by":"publisher","first-page":"100320","DOI":"10.1016\/j.jbc.2021.100320","volume":"296","author":"T Kambe","year":"2021","unstructured":"Kambe T, Taylor KM, Fu D. Zinc transporters and their functional integration in mammalian cells. J Biol Chem. 2021;296:100320.","journal-title":"J Biol Chem"},{"issue":"3","key":"2146_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/jcp.21.3.359","volume":"21","author":"IJ Davies","year":"1968","unstructured":"Davies IJ, Musa M, Dormandy TL. Measurements of plasma zinc. I. In health and disease. J Clin Pathol. 1968;21(3):359\u201363.","journal-title":"J Clin Pathol"},{"issue":"16","key":"2146_CR19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1089\/scd.2018.0023","volume":"27","author":"KH Park","year":"2018","unstructured":"Park KH, Choi Y, Yoon DS, Lee KM, Kim D, Lee JW. Zinc promotes osteoblast differentiation in human mesenchymal stem cells via activation of the cAMP-PKA-CREB signaling pathway. Stem Cells Dev. 2018;27(16):1125\u201335.","journal-title":"Stem Cells Dev"},{"issue":"3","key":"2146_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1053\/j.gastro.2018.10.026","volume":"156","author":"J Yang","year":"2019","unstructured":"Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, et al. ZIP4 promotes muscle wasting and Cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells. Gastroenterology. 2019;156(3):722\u201334.","journal-title":"Gastroenterology"},{"issue":"11","key":"2146_CR21","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.3390\/cancers12113166","volume":"12","author":"L Sapio","year":"2020","unstructured":"Sapio L, Salzillo A, Ragone A, Illiano M, Spina A, Naviglio S. Targeting CREB in cancer therapy: a key candidate or one of many? An update. Cancers (Basel). 2020;12(11):3166.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2146_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/pr050361j","volume":"5","author":"C Andreini","year":"2006","unstructured":"Andreini C, Banci L, Bertini I, Rosato A. Counting the zinc-proteins encoded in the human genome. J Proteome Res. 2006;5(1):196\u2013201.","journal-title":"J Proteome Res"},{"issue":"8","key":"2146_CR23","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/j.1349-7006.2008.00854.x","volume":"99","author":"M Murakami","year":"2008","unstructured":"Murakami M, Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci. 2008;99(8):1515\u201322.","journal-title":"Cancer Sci"},{"issue":"35","key":"2146_CR24","doi-asserted-by":"publisher","first-page":"59950","DOI":"10.18632\/oncotarget.19048","volume":"8","author":"HC Zheng","year":"2017","unstructured":"Zheng HC. The molecular mechanisms of chemoresistance in cancers. Oncotarget. 2017;8(35):59950\u201364.","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"2146_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11010-008-9722-8","volume":"312","author":"C Lu","year":"2008","unstructured":"Lu C, Shervington A. Chemoresistance in gliomas. Mol Cell Biochem. 2008;312(1\u20132):71\u201380.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"2146_CR26","doi-asserted-by":"publisher","first-page":"188405","DOI":"10.1016\/j.bbcan.2020.188405","volume":"2020","author":"C Zheng","year":"1874","unstructured":"Zheng C, Tang F, Min L, Hornicek F, Duan Z, Tu C. PTEN in osteosarcoma: recent advances and the therapeutic potential. Biochim Biophys Acta Rev Cancer. 1874;2020(2):188405.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"2146_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper J, Giancotti FG. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell. 2019;35(3):347\u201367.","journal-title":"Cancer Cell"},{"issue":"8","key":"2146_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/nu4080875","volume":"4","author":"S Alam","year":"2012","unstructured":"Alam S, Kelleher SL. Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer. Nutrients. 2012;4(8):875\u2013903.","journal-title":"Nutrients"},{"issue":"7","key":"2146_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/nu4070648","volume":"4","author":"BJ Grattan","year":"2012","unstructured":"Grattan BJ, Freake HC. Zinc and cancer: implications for LIV-1 in breast cancer. Nutrients. 2012;4(7):648\u201375.","journal-title":"Nutrients"},{"issue":"1","key":"2146_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13018-020-01585-x","volume":"15","author":"K Gao","year":"2020","unstructured":"Gao K, Zhang Y, Niu J, Nie Z, Liu Q, Lv C. Zinc promotes cell apoptosis via activating the Wnt-3a\/beta-catenin signaling pathway in osteosarcoma. J Orthop Surg Res. 2020;15(1):57.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"2146_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/xrs.2727","volume":"46","author":"M Rauwolf","year":"2017","unstructured":"Rauwolf M, Pemmer B, Roschger A, Turyanskaya A, Smolek S, Maderitsch A, et al. Increased zinc accumulation in mineralized osteosarcoma tissue measured by confocal synchrotron radiation micro X-ray fluorescence analysis. Xray Spectrom. 2017;46(1):56\u201362.","journal-title":"Xray Spectrom"},{"issue":"9","key":"2146_CR32","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1007\/s12011-020-02466-4","volume":"199","author":"A Meshkini","year":"2021","unstructured":"Meshkini A. A correlation between intracellular zinc content and osteosarcoma. Biol Trace Elem Res. 2021;199(9):3222\u201331.","journal-title":"Biol Trace Elem Res"},{"key":"2146_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.colsurfb.2017.07.006","volume":"158","author":"A Meshkini","year":"2017","unstructured":"Meshkini A, Oveisi H. Methotrexate-F127 conjugated mesoporous zinc hydroxyapatite as an efficient drug delivery system for overcoming chemotherapy resistance in osteosarcoma cells. Colloids Surf B Biointerfaces. 2017;158:319\u201330.","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-021-02146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-021-02146-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-021-02146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T22:38:15Z","timestamp":1673649495000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-021-02146-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1186\/s13046-021-02146-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Eighth Affiliated Hospital, Sun Yat-sen University, China. All animal experimental procedures were approved by the institutional animal care and use committee of Sun Yat-Sen University, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}